Lifeaz raises €13 million to make defibrillators mainstream
Paris-based healthtech startup Lifeaz has secured a €13 million funding round to accelerate the roll-out of its connected defibrillators across Europe. The company’s mission is ambitious: democratise access to life‑saving devices and help save 1,000 lives within the next five years.
Founded to tackle the global burden of sudden cardiac arrest, Lifeaz designs compact, user‑friendly defibrillators intended for homes, workplaces and public spaces rather than just hospitals. By simplifying usage and integrating digital guidance, the company aims to empower non‑medical users to act quickly in emergencies.
Democratising access to life‑saving technology
Every year, hundreds of thousands of people suffer sudden cardiac arrest outside of hospital settings. Survival rates remain low, largely due to delays in first response and limited access to automated external defibrillators (AEDs). Lifeaz is positioning its connected devices as a critical layer in community‑level emergency care.
The startup’s defibrillators are designed to be always connected, enabling remote monitoring, predictive maintenance and software updates. Integrated voice and visual instructions guide users step‑by‑step, lowering the barrier for untrained bystanders to intervene. This approach aligns with broader trends in digital health and Internet of Medical Things (IoMT) solutions.
Scaling across Europe with fresh capital
The €13 million injection will be used to ramp up production, expand distribution partnerships and strengthen regulatory and clinical validation in key European markets. Lifeaz also plans to invest in data‑driven services, using anonymised usage data to improve device performance and inform public health strategies.
By targeting homes, small businesses and community organisations, the company hopes to build a dense network of accessible devices that can dramatically shorten time to treatment. If Lifeaz achieves its goal of saving 1,000 lives within five years, it could help redefine public expectations around everyday access to emergency medical technology and set a benchmark for preventive, decentralised cardiac care.